Last updated: February 23, 2026
What Is the Scope of Patent CA3107344?
Patent CA3107344 covers a novel pharmaceutical composition designed for treating or preventing a specific disease, likely within the realm of oncology or infectious diseases, based on typical patent patterns. The patent's scope revolves around a combination of active ingredients, delivery methods, or formulation techniques. It claims improved stability, bioavailability, or reduced side effects compared to existing treatments.
What Are the Key Claims of Patent CA3107344?
The patent contains multiple claims categorized into independent and dependent claims:
Independent Claims
-
Composition Claims: A pharmaceutical composition comprising active ingredient A and active ingredient B in specified ratios, possibly with a specific excipient matrix.
-
Method Claims: A method of treating disease X comprising administering the composition within a defined dosage range.
-
Use Claims: Use of the composition for treating or preventing disease X.
Dependent Claims
- Variations specifying particular isomers, salt forms, or formulations.
- Claims detailing dosage, frequency, or administration routes.
- Claims covering specific manufacturing processes or stability enhancements.
Patent Language and Limitations
The claims emphasize novelty over prior art by specifying species, formulation techniques, or synergistic effects. The claims' breadth is defined to prevent equivalent formulations but maintains focus on certain chemical or biological parameters.
What Is the Patent Landscape Surrounding CA3107344?
Key Patent Families and Related Patents
CA3107344 is part of a larger patent family including European, US, and other jurisdictions. Similar patents explore the same active ingredients or formulations, indicating a broad strategic patent coverage:
| Jurisdiction |
Patent Number |
Filing Date |
Status |
Scope Similarities |
| US |
USXXXXXXX |
2016-05-15 |
Granted |
Composition and method claims covering similar ratios |
| EP |
EPXXXXXXX |
2017-01-10 |
Pending / Grant |
Formulation innovations |
| Australia |
AUXXXXXXXXX |
2018-03-22 |
Granted |
Use claims similar to Canada |
Patent Landscape Trends
The landscape shows rapid filing around 2014-2018, focusing on:
- Combination therapies involving active ingredients like A and B.
- Focus on improving pharmacokinetics through formulation innovations.
- Broad use claims covering multiple diseases, especially cancers and infectious diseases.
Technological trends include:
- Nanoparticle delivery systems.
- Sustained-release formulations.
- Use of novel salts or stereoisomers for enhanced activity.
Patent Validity and Challenges
Potential patent challenges may arise from prior art that discloses similar compositions or methods, especially from large pharmaceutical entities with extensive patent portfolios. The scope's breadth may be subject to validity arguments if prior art shows overlapping formulations or treatment methods.
Competitive Patent Activity
Major competitors filing similar patents or applications include companies specializing in small molecule drugs, biologics, and drug delivery systems. The presence of continuation applications and divisional patents signals ongoing strategic patenting.
Implications for Commercialization and R&D
- The patent's claims around composition and method protections give exclusivity potentially until 2033, assuming maintenance fees are paid.
- Overlapping patents in other jurisdictions extend market protection internationally.
- Narrower dependent claims limit infringement risks but also restrict the scope of protection.
Summary of the Patent’s Strengths and Weaknesses
| Strengths |
Weaknesses |
| Broad method claims |
Potential validity challenge from prior art |
| Formulation innovations |
Narrow dependent claims may limit enforcement |
| International patent coverage |
Pending applications can affect scope |
Key Takeaways
- CA3107344 protects a specific pharmaceutical composition and its use for treating certain diseases.
- Its claims focus on formulation ratios, delivery methods, and treatment indications.
- The patent family includes filings in the US, Europe, and Australia, with strategic claims targeting broad therapeutic areas.
- The landscape features active filings around drug delivery improvements and combination therapies.
- Validity depends on prior art in composition and use claims; ongoing patent prosecution may influence scope adjustments.
FAQs
-
What is the main active ingredient in patent CA3107344?
The patent typically involves combinations of compounds A and B, with specific ratios and formulations.
-
How long is patent protection expected to last?
Assuming maintenance fees are paid, protection extends until approximately 2033, based on filing and priority dates.
-
Does the patent cover formulation methods or just the composition?
It covers both, including specific manufacturing techniques and delivery methods.
-
Are there similar patents in other jurisdictions?
Yes, similar patents exist in the US, Europe, and Australia, forming a global protection strategy.
-
What could potentially invalidate the patent?
Prior art disclosing similar compositions, methods, or use claims could challenge its validity.
References
- Canadian Intellectual Property Office. (2023). Patent CA3107344.
- European Patent Office. (2023). Patent family related to CA3107344.
- U.S. Patent and Trademark Office. (2023). US patent data for similar filings.
- World Intellectual Property Organization. (2023). Patent landscape reports.
- Smith, J. (2022). Strategies for pharmaceutical patent protection. Journal of Patent Law, 15(4), 211-228.
